Endometrial Neoplasms Clinical Trials

114 clinical trials for Endometrial Neoplasms across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of DM002 in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Study of LY4257496 in Participants With Cancer (OMNIRAY) — RECRUITING · PHASE1
• A Study of LY4175408 in Participants With Advanced Cancer — RECRUITING · PHASE1
• A Study of LY4170156 in Participants With Selected Advanced Solid Tumors — RECRUITING · PHASE1
• A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) — RECRUITING · PHASE2
• Uterine Manipulator Versus no Uterine Manipulator in Endometrial Cancer Trial — RECRUITING · NA
• Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma — RECRUITING · PHASE2
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• Registry Platform Ovarian and Endometrial Cancer — RECRUITING
• DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition — RECRUITING · PHASE2
• The Role of POLE Mutation in High Risk Endometrial Cancer. — RECRUITING
• GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients — RECRUITING · PHASE2
• GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients — RECRUITING · PHASE2
• Comparison of Two-Position and Four-Position Cervical Injection Techniques for Sentinel Lymph Node Mapping in Endometrial Cancer Using Methylene Blue — RECRUITING · NA
• DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics — RECRUITING
• Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC) — RECRUITING · PHASE2
• First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer — RECRUITING · PHASE2
• Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer — RECRUITING · NA
• Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer — RECRUITING · NA
• The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study. — RECRUITING
• Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer — COMPLETED · NA
• Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer — NOT_YET_RECRUITING · PHASE3
• Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) — ACTIVE_NOT_RECRUITING · PHASE3
• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 — ACTIVE_NOT_RECRUITING · PHASE2
• Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia — NOT_YET_RECRUITING · PHASE2
• Optimal Margin Evaluation of Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer — COMPLETED · PHASE2
• Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor — NOT_YET_RECRUITING · PHASE2
• Online Adaptive Radiotherapy for Postoperative Treatment of Endometrial and Cervical Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — ACTIVE_NOT_RECRUITING · PHASE1
• Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Mismatch Repair Deficient (dMMR) Advanced or Recurrent Endometrial Carcinoma (MK-3475-C93/KEYNOTE-C93/GOG-3064/ENGOT-en15) — ACTIVE_NOT_RECRUITING · PHASE3
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors — COMPLETED · NA
• A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor — ACTIVE_NOT_RECRUITING · PHASE1
• Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775]) — COMPLETED · PHASE3
• Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) — COMPLETED · PHASE3
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors — TERMINATED · PHASE1
• Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up — NOT_YET_RECRUITING
• Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Versus Chemotherapy for Endometrial Carcinoma (ENGOT-en9 / MK-7902-001) - China Extension Study — COMPLETED · PHASE3
• Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors — TERMINATED · PHASE1
• Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer — COMPLETED · NA
• MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) — COMPLETED · PHASE2
• A Study of PF-07260437 in Advanced or Metastatic Solid Tumors — TERMINATED · PHASE1
• Effect of Pelvic Radiotherapy on the Intestinal Microbiome and Metabolome — COMPLETED
• Study of AK112 in the Treatment of Advanced Gynecological Tumors — COMPLETED · PHASE2
• A Study of SGN-ALPV in Advanced Solid Tumors — TERMINATED · PHASE1
• A Study of SGN-STNV in Advanced Solid Tumors — TERMINATED · PHASE1
• Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy? — COMPLETED · NA
• Characterization of the Genetic Profile of Type 2 Endometrial Carcinoma in Martinique — COMPLETED
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) — TERMINATED · PHASE1

Refine this search